Suscripción a Biblioteca: Guest
Critical Reviews™ in Neurobiology

Publicado 3 números por año

ISSN Imprimir: 0892-0915

ISSN En Línea: 2375-0014

SJR: 0.121

Neuropharmacological Mechanisms of Drug Reward: Beyond Dopamine in the Nucleus Accumbens

Volumen 12, Edición 1-2, 1998, pp. 37-68
DOI: 10.1615/CritRevNeurobiol.v12.i1-2.30
Get accessGet access

SINOPSIS

Multiple lines of research have implicated the mesolimbic dopamine system in drug reward measured by either the drug self-administration or conditioned place preference paradigm. The present review summarizes recent work that examines the neuropharmacological mechanisms by which drugs impinge on this dopaminergic neural circuitry, as well as other systems that provide input and output circuits to the mesolimbic dopamine system. Studies examining the effect of selective agonist and antagonist drugs administered systemically have indicated that multiple neurotransmitters are involved, including dopamine, serotonin, acetylcholine, glutamate, GABA, and various peptides. Direct microinjection studies have also provided crucial evidence indicating that, in addition to the mesolimbic dopamine system, other structures play a role in drug reward, including the ventral pallidum, amygdala, hippocampus, hypothalamus, and pedunculopontine tegmental nucleus. GABAergic circuitry descending from the nucleus accumbens to the pedunculopontine tegmental nucleus via the ventral pallidum appears to be especially important in directing the behavioral sequelae associated with reward produced by various drags of abuse. However, activation of the reward circuitry is achieved differently for various drugs of abuse. With amphetamine and cocaine, initiation of reward is controlled within the nucleus accumbens and prefrontal cortex, respectively. With opiates, initiation of reward involves the ventral tegmental area, nucleus accumbens, hippocampus, and hypothalamus. It is not clear presently if these multiple anatomical structures mediate opiate reward by converging on a single output system or multiple output systems.

CITADO POR
  1. SZIRAKI ISTVAN, SERSHEN HENRY, BENUCK MYRON, HASHIM AUDREY, LAJTHA ABEL, Differences in Receptor System Participation between Nicotine- and Cocaine-induced Dopamine Overflow in Nucleus Accumbens, Annals of the New York Academy of Sciences, 877, 1 ADVANCING FRO, 1999. Crossref

  2. AL-Eitan Laith N, Jaradat Saied A, Hulse Gary K, Tay Guan K, Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent, BMC Research Notes, 5, 1, 2012. Crossref

  3. Saal Daniel, Nemeroff Charles B., Novel Pharmacologic Treatment of Stress and Addiction, in Stress and Addiction, 2007. Crossref

  4. Narita Minoru, Kato Hideaki, Kasukawa Akiko, Narita Michiko, Suzuki Masami, Takeuchi Tomoko, Suzuki Tsutomu, Role of Src family kinase in the rewarding effect and hyperlocomotion induced by morphine, NeuroReport, 17, 2, 2006. Crossref

  5. Xi Zheng-Xiong, Peng Xiao-Qing, Li Xia, Song Rui, Zhang Hai-Ying, Liu Qing-Rong, Yang Hong-Ju, Bi Guo-Hua, Li Jie, Gardner Eliot L, Brain cannabinoid CB2 receptors modulate cocaine's actions in mice, Nature Neuroscience, 14, 9, 2011. Crossref

  6. Caillé Stéphanie, Parsons Loren H, Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway, Neuropsychopharmacology, 31, 4, 2006. Crossref

  7. Dilleen Ruth, Pelloux Yann, Mar Adam C., Molander Anna, Robbins Trevor W., Everitt Barry J., Dalley Jeffrey W., Belin David, High anxiety is a predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats, Psychopharmacology, 222, 1, 2012. Crossref

  8. Telang Frank W., Vblkow Nora D., Addictive States, in Brain Mapping: The Disorders, 2000. Crossref

  9. Kemppainen Heidi, Raivio Noora, Kiianmaa Kalervo, Role for ventral pallidal GABAergic mechanisms in the regulation of ethanol self-administration, Psychopharmacology, 223, 2, 2012. Crossref

  10. Meririnne Esa, Kajos Miina, Kankaanpaa Aino, Seppala Timo, Rewarding Properties of 1-Benzylpiperazine, a New Drug of Abuse, in Rats, Basic <html_ent glyph="@amp;" ascii="&amp;"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&amp;"/> Toxicology, 98, 4, 2006. Crossref

  11. Lin Sharon J., Epps S. Alisha, West Charles H., Boss-Williams Katherine A., Weiss Jay M., Weinshenker David, Operant psychostimulant self-administration in a rat model of depression, Pharmacology Biochemistry and Behavior, 103, 2, 2012. Crossref

  12. Saellstroem Baum S., Huebner Anke, Krimphove M., Morgenstern Rudolf, Badawy Abdulla A.-B., Spies Claudia D., Nicotine Stimulation on Extracellular Glutamate Levels in the Nucleus Accumbens of Ethanol-withdrawn Rats In Vivo, Alcoholism: Clinical and Experimental Research, 30, 8, 2006. Crossref

  13. Staub D.R., Lunden J.W., Cathel A.M., Dolben E.L., Kirby L.G., Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats, Psychoneuroendocrinology, 37, 6, 2012. Crossref

  14. Guzman Daniel, Ettenberg Aaron, Runway self-administration of intracerebroventricular cocaine: evidence of mixed positive and negative drug actions, Behavioural Pharmacology, 18, 1, 2007. Crossref

  15. Caille Stephanie, Parsons Loren H., Intravenous heroin self-administration decreases GABA efflux in the ventral pallidum: an in vivo microdialysis study in rats, European Journal of Neuroscience, 20, 2, 2004. Crossref

  16. Demchyshyn Lidia, O’Dowd Brian, George Susan, Structure of Mammalian D1 and D5 Dopamine Receptors and Their Function and Regulation in Cells, in Dopamine Receptors and Transporters, 2003. Crossref

  17. Dewey Stephen L., Brodie Jonathan D., Gerasimov Madina, Horan Bryan, Gardner Eliot L., Ashby Charles R., A pharmacologic strategy for the treatment of nicotine addiction, Synapse, 31, 1, 1999. Crossref

  18. Mengual Elisa, Pickel Virginia M., Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum, Synapse, 43, 3, 2002. Crossref

  19. Panagis George, Hildebrand Bengt E., Svensson Torgny H., Nomikos George G., Selectivec-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome, Synapse, 35, 1, 2000. Crossref

  20. Zarrindast Mohammad-Reza, Heidari-Darvishani Ahmad, Rezayof Ameneh, Fathi-Azarbaijani Fathollah, Jafari-Sabet Majid, Hajizadeh-Moghaddam Akbar, Morphine-induced sensitization in mice: changes in locomotor activity by prior scheduled exposure to GABAA receptor agents, Behavioural Pharmacology, 18, 4, 2007. Crossref

  21. Kalenscher Tobias, Diekamp Bettina, Gunturkun Onur, Neural architecture of choice behaviour in a concurrent interval schedule, European Journal of Neuroscience, 18, 9, 2003. Crossref

  22. Tzschentke Thomas M., Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addiction Biology, 12, 3-4, 2007. Crossref

  23. Mengual Elisa, Pickel Virginia M., Regional and subcellular compartmentation of the dopamine transporter and tyrosine hydroxylase in the rat ventral pallidum, The Journal of Comparative Neurology, 468, 3, 2004. Crossref

  24. Moreno M., Economidou D., Mar A. C., López-Granero C., Caprioli D., Theobald D. E., Fernando A., Newman A. H., Robbins T. W., Dalley Jeffrey W., Divergent effects of D2/3 receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats, Psychopharmacology, 228, 1, 2013. Crossref

  25. Gingrich Brenden, Liu Yan, Cascio Carissa, Wang Zuoxin, Insel Thomas R., Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster)., Behavioral Neuroscience, 114, 1, 2000. Crossref

  26. Gerasimov Madina R., Ashby Charles R., Gardner Eliot L., Mills Mark J., Brodie Jonathan D., Dewey Stephen L., Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine, Synapse, 34, 1, 1999. Crossref

  27. Sofuoglu Mehmet, Lappalainen Jaakko, GABAergic Agents for the Treatment of Nicotine Dependence, in Medication Treatments for Nicotine Dependence, 2006. Crossref

  28. Frantz Kyle J, O'Dell Laura E, Parsons Loren H, Behavioral and Neurochemical Responses to Cocaine in Periadolescent and Adult Rats, Neuropsychopharmacology, 32, 3, 2007. Crossref

  29. Weinshenker David, Schroeder Jason P, There and Back Again: A Tale of Norepinephrine and Drug Addiction, Neuropsychopharmacology, 32, 7, 2007. Crossref

  30. Sun Dongxiao, Huang Weihua, Hwang Yoon Y, Zhang Yuan, Zhang Qin, Li Ming D, Regulation by Nicotine of Gpr51 and Ntrk2 Expression in Various Rat Brain Regions, Neuropsychopharmacology, 32, 1, 2007. Crossref

  31. Golovko A. I., Golovko S. I., Leontieva L. V., The neurochemistry of the psychological dependence syndrome in addictive diseases of chemical etiology, Neurochemical Journal, 1, 1, 2007. Crossref

  32. Kelz Max B., Nestler Eric J., ΔFosB: a molecular switch underlying long-term neural plasticity, Current Opinion in Neurology, 13, 6, 2000. Crossref

  33. Chandler-Laney Paula C., Castañeda Edward, Viana Jason B., Oswald Kimberly D., Maldonado Christine R., Boggiano Mary M., A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating, International Journal of Eating Disorders, 40, 2, 2007. Crossref

  34. Kalivas Peter W., A role for glutamate transmission in addiction to psychostimulants, Addiction Biology, 5, 3, 2000. Crossref

  35. Yue Kai, Ma Baomiao, Chen Lin, Tian Xiang, Ru Qin, Gan Yongping, Wang Daisong, Jin Guozhang, Li Chaoying, L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats, NeuroReport, 25, 1, 2014. Crossref

  36. Newman Amy Hauck, Kulkarni Santosh, Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic?A focus on analogues of benztropine and rimcazole, Medicinal Research Reviews, 22, 5, 2002. Crossref

  37. Mattson B. J., Williams S., Rosenblatt J. S., Morrell J. I., Comparison of two positive reinforcing stimuli: Pups and cocaine throughout the postpartum period., Behavioral Neuroscience, 115, 3, 2001. Crossref

  38. Miller Dennis K., Oelrichs Clark E., Sage Andrew S., Sun Grace Y., Simonyi Agnes, Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents, Neuroscience Letters, 554, 2013. Crossref

  39. Rokosik Sandra L., Persons Amanda L., Napier T. Celeste, Sensitization by ventral pallidal DAMGO, NeuroReport, 24, 3, 2013. Crossref

  40. Silverman Daniel H. S., Cerebral activity in the perception of visceral pain, Current Review of Pain, 3, 4, 1999. Crossref

  41. Williams Mark J, Adinoff Bryon, The Role of Acetylcholine in Cocaine Addiction, Neuropsychopharmacology, 33, 8, 2008. Crossref

  42. Bahi Amine, The oxytocin receptor impairs ethanol reward in mice, Physiology & Behavior, 139, 2015. Crossref

  43. Ravna Aina W., Sylte Ingebrigt, Dahl Svein G., Structure and localisation of drug binding sites on neurotransmitter transporters, Journal of Molecular Modeling, 15, 10, 2009. Crossref

  44. Befort K., Filliol D., Ghate A., Darcq E., Matifas A., Muller J., Lardenois A., Thibault C., Dembele D., Le Merrer J., Becker J. A. J., Poch O., Kieffer B. L., Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala, European Journal of Neuroscience, 27, 11, 2008. Crossref

  45. Hachimine P., Seepersad N., Ananthan S., Ranaldi R., The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats, Neuroscience Letters, 569, 2014. Crossref

  46. Müller Christian P., Schumann Gunter, Drugs as instruments: A new framework for non-addictive psychoactive drug use, Behavioral and Brain Sciences, 34, 6, 2011. Crossref

  47. Sakoori Kazuto, Murphy Niall P, Endogenous Nociceptin (Orphanin FQ) Suppresses Basal Hedonic State and Acute Reward Responses to Methamphetamine and Ethanol, but Facilitates Chronic Responses, Neuropsychopharmacology, 33, 4, 2008. Crossref

  48. Pirisino Renato, Galeotti Nicoletta, Livi Silvia, Raimondi Laura, Ghelardini Carla, 4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels, British Journal of Pharmacology, 147, 2, 2006. Crossref

  49. Kumar P., Waiter G., Ahearn T., Milders M., Reid I., Steele J. D., Abnormal temporal difference reward-learning signals in major depression, Brain, 131, 8, 2008. Crossref

  50. Becker Axel, Schmitz Marco, Grecksch Gisela, Kindling modifies morphine, cocaine and ethanol place preference, Experimental Brain Research, 168, 1-2, 2006. Crossref

  51. Zhang Jie, Tan Hua, Niu Hai C., Wang Jian H., Tang Xiang D., Sanford Larry D., Ma Yuan-Ye, Pentylenetetrazole-induced status epilepticus following training does not impair expression of morphine-induced conditioned place preference, Addiction Biology, 14, 2, 2009. Crossref

  52. Luo Zhongchi, Yuan Zhijia, Tully Melissa, Pan Yingtian, Du Congwu, Quantification of cocaine-induced cortical blood flow changes using laser speckle contrast imaging and Doppler optical coherence tomography, Applied Optics, 48, 10, 2009. Crossref

  53. Sofuoglu Mehmet, Mooney Marc, Kosten Thomas, Waters Andrew, Hashimoto Kenji, Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans, Psychopharmacology, 213, 1, 2011. Crossref

  54. Sofuoglu Mehmet, Kosten Thomas R, Emerging pharmacological strategies in the fight against cocaine addiction, Expert Opinion on Emerging Drugs, 11, 1, 2006. Crossref

  55. Sumithran Sangeetha P., Crooks Peter A., Xu Rui, Zhu Jun, Deaciuc Agripina G., Wilkins Lincoln H., Dwoskin Linda P., Introduction of unsaturation into theN-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: Effect on affinity and selectivity, The AAPS Journal, 7, 1, 2005. Crossref

  56. Hart Carl L, Haney Margaret, Vosburg Suzanne K, Rubin Eric, Foltin Richard W, Smoked Cocaine Self-Administration is Decreased by Modafinil, Neuropsychopharmacology, 33, 4, 2008. Crossref

  57. Zhu Jun, Bardo Michael T., Green Thomas A., Wedlund Peter J., Dwoskin Linda P., Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environment, Journal of Neurochemistry, 2007. Crossref

  58. Shahbazi Mahin, Moffett Aimee M., Williams Bonnie F., Frantz Kyle J., Age- and sex-dependent amphetamine self-administration in rats, Psychopharmacology, 196, 1, 2008. Crossref

  59. Tzschentke Thomas M., Schmidt Werner J., Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization, European Journal of Neuroscience, 11, 11, 1999. Crossref

  60. Mattson B.J., Morrell J.I., Preference for cocaine- versus pup-associated cues differentially activates neurons expressing either Fos or cocaine- and amphetamine-regulated transcript in lactating, maternal rodents, Neuroscience, 135, 2, 2005. Crossref

  61. ZATORRE ROBERT J., Music and the Brain, Annals of the New York Academy of Sciences, 999, 1, 2003. Crossref

  62. Hill Kevin P, Sofuoglu Mehmet, Biological Treatments for Amfetamine Dependence, CNS Drugs, 21, 10, 2007. Crossref

  63. Buffalari D.M., Rinaman L., Cocaine self-administration and extinction alter medullary noradrenergic and limbic forebrain cFos responses to acute, noncontingent cocaine injections in adult rats, Neuroscience, 281, 2014. Crossref

  64. Lester Deranda B, Rogers Tiffany D., Blaha Charles D., Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders, CNS Neuroscience & Therapeutics, 16, 3, 2010. Crossref

  65. Fujio Mayumi, Nakagawa Takayuki, Sekiya Yumiko, Ozawa Tohru, Suzuki Yuichi, Minami Masabumi, Satoh Masamichi, Kaneko Shuji, Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats, European Journal of Neuroscience, 22, 11, 2005. Crossref

  66. Wang Hui-Ling, Morales Marisela, Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat, European Journal of Neuroscience, 29, 2, 2009. Crossref

  67. Forster Gina L., Blaha Charles D., Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area, European Journal of Neuroscience, 12, 10, 2000. Crossref

  68. Turner Michael S., Gray Thackery S., Mickiewicz Amanda L., Napier T. Celeste, Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson’s Disease: implications for limbic system and basal ganglia interactions, Brain Structure and Function, 213, 1-2, 2008. Crossref

  69. Miller A.D., Forster G.L., Yeomans J.S., Blaha C.D., Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat, Neuroscience, 136, 2, 2005. Crossref

  70. Guitart-Masip Marc, Giménez-Llort Lydia, Fernández-Teruel Albert, Cañete Toni, Tobeña Adolf, Ögren Sven Ove, Terenius Lars, Johansson Björn, Reduced ethanol response in the alcohol-preferring RHA rats and neuropeptide mRNAs in relevant structures, European Journal of Neuroscience, 23, 2, 2006. Crossref

  71. Xi Zheng‐Xiong, Gardner Eliot L., Pharmacological Actions of NGB 2904, a Selective Dopamine D 3 Receptor Antagonist, in Animal Models of Drug Addiction , CNS Drug Reviews, 13, 2, 2007. Crossref

  72. Kamal Amer, Van der Harst Johanneke E., Kapteijn Chantal M., Baars Annemarie J. M., Spruijt Berry M., Ramakers Geert M. J., Announced reward counteracts the effects of chronic social stress on anticipatory behavior and hippocampal synaptic plasticity in rats, Experimental Brain Research, 201, 4, 2010. Crossref

  73. Lupica Carl R, Riegel Arthur C, Hoffman Alexander F, Marijuana and cannabinoid regulation of brain reward circuits, British Journal of Pharmacology, 143, 2, 2004. Crossref

  74. ROBERTS DAVID C.S., BREBNER KAREN, GABA Modulation of Cocaine Self-Administration, Annals of the New York Academy of Sciences, 909, 1, 2006. Crossref

  75. Newman Amy Hauck, Novel pharmacotherapies for cocaine abuse 1997 - 2000, Expert Opinion on Therapeutic Patents, 10, 7, 2000. Crossref

  76. Lindblom Jonas, Johansson Andreas, Holmgren Andreas, Grandin Elisabeth, Nedergård Carina, Fredriksson Robert, Schiöth Helgi B., Increased mRNA levels of tyrosine hydroxylase and dopamine transporter in the VTA of male rats after chronic food restriction, European Journal of Neuroscience, 23, 1, 2006. Crossref

  77. Shabani S., Foster R., Gubner N., Phillips T.J., Mark G.P., Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats, Neuroscience, 170, 2, 2010. Crossref

  78. Tropea Thomas F., Kosofsky Barry E., Rajadhyaksha Anjali M., Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior, Journal of Neurochemistry, 106, 4, 2008. Crossref

  79. Kim Tae-Suk, Kondo Douglas G, Kim Namkug, Renshaw Perry F, Altitude May Contribute to Regional Variation in Methamphetamine Use in the United States: A Population Database Study, Psychiatry Investigation, 11, 4, 2014. Crossref

  80. Giorgi Osvaldo, Corda Maria G., Sabariego Marta, Giugliano Valentina, Piludu Maria A., Rosas Michela, Acquas Elio, Differential effects of cocaine on extracellular signal-regulated kinase phosphorylation in nuclei of the extended amygdala and prefrontal cortex of psychogenetically selected roman high- and low-avoidance rats, Journal of Neuroscience Research, 93, 5, 2015. Crossref

  81. Chen J.-F, Beilstein M, Xu Y.-H, Turner T.J, Moratalla R, Standaert D.G, Aloyo V.J, Fink J.S, Schwarzschild M.A, Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A2A adenosine receptors, Neuroscience, 97, 1, 2000. Crossref

  82. Hansen Stephen T., Mark Gregory P., The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access, Psychopharmacology, 194, 1, 2007. Crossref

  83. Meririnne Esa, Kajos Miina, Kankaanpää Aino, Koistinen Meri, Kiianmaa Kalervo, Seppälä Timo, Rewarding properties of the stereoisomers of 4-methylaminorex: Involvement of the dopamine system, Pharmacology Biochemistry and Behavior, 81, 4, 2005. Crossref

  84. Kiefer Falk, Complete Suppression of Craving in Alcohol-Dependent Individuals, CNS Drugs, 23, 5, 2009. Crossref

  85. Sofuoglu Mehmet, Sewell R. Andrew, Norepinephrine and stimulant addiction, Addiction Biology, 14, 2, 2009. Crossref

  86. Ho Chao-Yi, Berridge Kent C., Excessive disgust caused by brain lesions or temporary inactivations: mapping hotspots of the nucleus accumbens and ventral pallidum, European Journal of Neuroscience, 40, 10, 2014. Crossref

  87. McDougall S.A., Reichel C.M., Farley C.M., Flesher M.M., Der-Ghazarian T., Cortez A.M., Wacan J.J., Martinez C.E., Varela F.A., Butt A.E., Crawford C.A., Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes, Neuroscience, 154, 2, 2008. Crossref

  88. Lack Christopher M., Jones Sara R., Roberts David C. S., Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats, Psychopharmacology, 195, 4, 2007. Crossref

  89. Fox Helen, Sinha Rajita, The Role of Guanfacine as a Therapeutic Agent to Address Stress-Related Pathophysiology in Cocaine-Dependent Individuals, in Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse, 69, 2014. Crossref

  90. Baransel Isir Aysun Baransel, Oguzkan Sibel, Nacak Muradiye, Gorucu Senay, Dulger Hikmet Ergin, Arslan Ahmet, The Catechol-O-Methyl Transferase Val158Met Polymorphism and Susceptibility to Cannabis Dependence, American Journal of Forensic Medicine & Pathology, 29, 4, 2008. Crossref

  91. Ersche Karen D, Sahakian Barbara J, The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment, Neuropsychology Review, 17, 3, 2007. Crossref

  92. Pereira Frederico C., Rolo Marta R., Marques Elsa, Mendes Vera M., Ribeiro Carlos F., Ali Syed F., Morgadinho Teresa, Macedo Tice R., Acute Increase of the Glutamate-Glutamine Cycling in Discrete Brain Areas after Administration of a Single Dose of Amphetamine, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  93. Gardner Eliot L., Addictive potential of cannabinoids: the underlying neurobiology, Chemistry and Physics of Lipids, 121, 1-2, 2002. Crossref

  94. Cousins Michael S., Roberts David C.S., Wit Harriet de, GABAB receptor agonists for the treatment of drug addiction: a review of recent findings, Drug and Alcohol Dependence, 65, 3, 2002. Crossref

  95. Fletcher Paul J., Azampanah Arezou, Korth Karin M., Activation of 5-HT1B receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule, Pharmacology Biochemistry and Behavior, 71, 4, 2002. Crossref

  96. Bardo M.T, Gehrke B.J, Shortridge B.E, Rauhut A.S, Effects of β-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity, Pharmacology Biochemistry and Behavior, 74, 3, 2003. Crossref

  97. Geary Emily H., Akins Chana K., Cocaine sensitization in male quail: Temporal, conditioning, and dose-dependent characteristics, Physiology & Behavior, 90, 5, 2007. Crossref

  98. Sziráki István, Sershen Henry, Benuck Myron, Hashim Audrey, Lajtha Abel, Receptor systems participating in nicotine-specific effects, Neurochemistry International, 33, 5, 1998. Crossref

  99. Miller Dennis K, Nation Jack R, Bratton Gerald R, Perinatal exposure to lead attenuates the conditioned reinforcing properties of cocaine in male rats, Pharmacology Biochemistry and Behavior, 67, 1, 2000. Crossref

  100. Yoon Seong Shoon, Kim Hongyu, Choi Kwang-Ho, Lee Bong Hyo, Lee Yoon Kyoung, Lim Sung Chul, Choi Seong Hun, Hwang Meeyul, Kim Kwang Joong, Yang Chae Ha, Acupuncture suppresses morphine self-administration through the GABA receptors, Brain Research Bulletin, 81, 6, 2010. Crossref

  101. Ferraro T.N, Golden G.T, Berrettini W.H, Gottheil E, Yang C.H, Cuppels G.R, Vogel W.H, Cocaine Intake by Rats Correlates with Cocaine-Induced Dopamine Changes in the Nucleus Accumbens Shell, Pharmacology Biochemistry and Behavior, 66, 2, 2000. Crossref

  102. Celik Eylem, Uzbay I. Tayfun, Karakas Sirel, Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1, 2006. Crossref

  103. Stock Howard S, Ford Kris, Wilson Marlene A, Gender and gonadal hormone effects in the olfactory bulbectomy animal model of depression, Pharmacology Biochemistry and Behavior, 67, 1, 2000. Crossref

  104. Ploj Karolina, Roman Erika, Gustavsson Lisa, Nylander Ingrid, Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice, Brain Research Bulletin, 53, 2, 2000. Crossref

  105. Serrano Antonia, Parsons Loren H., Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors, Pharmacology & Therapeutics, 132, 3, 2011. Crossref

  106. Lecca Daniele, Piras Giovanna, Driscoll Peter, Giorgi Osvaldo, Corda Maria G, A differential activation of dopamine output in the shell and core of the nucleus accumbens is associated with the motor responses to addictive drugs: a brain dialysis study in Roman high- and low-avoidance rats, Neuropharmacology, 46, 5, 2004. Crossref

  107. Diller Anna J., Rocha Angelica, Cardon Aaron L., Valles Rodrigo, Wellman Paul J., Nation Jack R., The effects of concurrent administration of (±)3,4-Methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat, Pharmacology Biochemistry and Behavior, 88, 2, 2007. Crossref

  108. Sofuoglu Mehmet, Waters Andrew J., Mooney Marc, Kosten Thomas, Riluzole and d-amphetamine interactions in humans, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 1, 2008. Crossref

  109. Sharf Ruth, Sarhan Maysa, DiLeone Ralph J., Orexin Mediates the Expression of Precipitated Morphine Withdrawal and Concurrent Activation of the Nucleus Accumbens Shell, Biological Psychiatry, 64, 3, 2008. Crossref

  110. Zarrindast Mohammad Reza, Karami Manizheh, Sepehri Houri, Sahraei Hedayat, Influence of nitric oxide on morphine-induced conditioned place preference in the rat central amygdala, European Journal of Pharmacology, 453, 1, 2002. Crossref

  111. Licata Stephanie C., Rowlett James K., Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond, Pharmacology Biochemistry and Behavior, 90, 1, 2008. Crossref

  112. Higgins Guy A, Fletcher Paul J, Serotonin and drug reward: focus on 5-HT2C receptors, European Journal of Pharmacology, 480, 1-3, 2003. Crossref

  113. Sharf Ruth, Sarhan Maysa, Brayton Catherine E., Guarnieri Douglas J., Taylor Jane R., DiLeone Ralph J., Orexin Signaling Via the Orexin 1 Receptor Mediates Operant Responding for Food Reinforcement, Biological Psychiatry, 67, 8, 2010. Crossref

  114. Mitchell I.J, Cooper A.J, Griffiths M.R, The selective vulnerability of striatopallidal neurons, Progress in Neurobiology, 59, 6, 1999. Crossref

  115. Wu Jing, Xiao Haifan, Sun Hongjuan, Zou Li, Zhu Ling-Qiang, Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis, Molecular Neurobiology, 45, 3, 2012. Crossref

  116. Karami Manizheh, Zarrindast Mohammad Reza, Sepehri Houri, Sahraei Hedayat, Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference, European Journal of Pharmacology, 449, 1-2, 2002. Crossref

  117. Cunningham Christopher L., Howard MacKenzie A., Gill Sylvia J., Rubinstein Marcelo, Low Malcolm J., Grandy David K., Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice, Pharmacology Biochemistry and Behavior, 67, 4, 2000. Crossref

  118. Miller A.D, Forster G.L, Metcalf K.M, Blaha C.D, Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors, Neuroscience, 111, 2, 2002. Crossref

  119. Yan Qing-Shan, Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission, Brain Research Bulletin, 51, 1, 2000. Crossref

  120. Rodriguez-Alarcón G., Canales J.J., Salvador A., Rewarding effects of 3,4-methylenedioxymethamphetamine (“Ecstasy”) in dominant and subordinate OF-1 mice in the place preference conditioning paradigm, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 1, 2007. Crossref

  121. Sage Andrew S., Vannest Scott C., Fan Kuo-Hsien, Will Matthew J., Lever Susan Z., Lever John R., Miller Dennis K., N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice, ISRN Pharmacology, 2013, 2013. Crossref

  122. McLay Robert N, Pan Weihong, Kastin Abba J, Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides, Peptides, 22, 12, 2001. Crossref

  123. Tzschentke Thomas M., Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues, Progress in Neurobiology, 56, 6, 1998. Crossref

  124. Panagis George, Kastellakis Andreas, The effects of ventral tegmental administration of GABAA, GABAB, NMDA and AMPA receptor agonists on ventral pallidum self-stimulation, Behavioural Brain Research, 131, 1-2, 2002. Crossref

  125. Will Matthew J, Der-Avakian Andre, Pepin Julie L, Durkan Brandice T, Watkins Linda R, Maier Steven F, Modulation of the locomotor properties of morphine and amphetamine by uncontrollable stress, Pharmacology Biochemistry and Behavior, 71, 1-2, 2002. Crossref

  126. Van Skike C.E., Maggio S.E., Reynolds A.R., Casey E.M., Bardo M.T., Dwoskin L.P., Prendergast M.A., Nixon K., Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 65, 2016. Crossref

  127. Sharifzadeh Mohammad, Haghighat Atieh, Tahsili-Fahadan Pouya, Khalaj Siavash, Zarrindast Mohammad-Reza, Zamanian Ali-Reza, Intra-hippocampal inhibition of protein kinase AII attenuates morphine-induced conditioned place preference, Pharmacology Biochemistry and Behavior, 85, 4, 2006. Crossref

  128. Brust John C.M., La neurobiologie de l'addiction, in Aspects neurologiques de l'addiction, 2007. Crossref

  129. Hao Yue, Yang Jingyu, Sun Jiye, Qi Jia, Dong Yingxu, Wu Chun Fu, Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice, Neuroscience Letters, 433, 1, 2008. Crossref

  130. Wang Zuoxin, Aragona Brandon J., Neurochemical regulation of pair bonding in male prairie voles, Physiology & Behavior, 83, 2, 2004. Crossref

  131. Sofuoglu Mehmet, Poling James, Mitchell Ellen, Kosten Thomas R., Tiagabine affects the subjective responses to cocaine in humans, Pharmacology Biochemistry and Behavior, 82, 3, 2005. Crossref

  132. Esmaeili Mohammad-Hossein, Kermani Mojtaba, Parvishan Asghar, Haghparast Abbas, Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area, Behavioural Brain Research, 231, 1, 2012. Crossref

  133. Wu Wei-Ran, Zhu Xing-Zu, The amphetamine-like reinforcing effect and mechanism of l-deprenyl on conditioned place preference in mice, European Journal of Pharmacology, 364, 1, 1999. Crossref

  134. Quarta Davide, Di Francesco Carla, Melotto Sergio, Mangiarini Laura, Heidbreder Christian, Hedou Gael, Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens, Neurochemistry International, 54, 2, 2009. Crossref

  135. Sharf Ruth, Lee David Y., Ranaldi Robert, Microinjections of SCH 23390 in the ventral tegmental area reduce operant responding under a progressive ratio schedule of food reinforcement in rats, Brain Research, 1033, 2, 2005. Crossref

  136. Ivanov Iliyan S., Schuiz Kurt P., Palmero Robyn C., Newcorn Jeffrey H., Neurorobiology and Evidence-Based Biological Treatments for Substance Abuse Disorders, CNS Spectrums, 11, 11, 2006. Crossref

  137. Jarosz Patricia A., Sekhon Phawanjit, Coscina Donald V., Effect of opioid antagonism on conditioned place preferences to snack foods, Pharmacology Biochemistry and Behavior, 83, 2, 2006. Crossref

  138. Ma Jingyi, Leung L. Stan, GABAB receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats, Psychopharmacology, 217, 2, 2011. Crossref

  139. Goodman Aviel, Neurobiology of addiction, Biochemical Pharmacology, 75, 1, 2008. Crossref

  140. Savelieva Katerina V., Caudle W. Michael, Miller Gary W., Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice, Alcohol, 40, 2, 2006. Crossref

  141. Giorgi Osvaldo, Piras Giovanna, Corda Maria G., The psychogenetically selected Roman high- and low-avoidance rat lines: A model to study the individual vulnerability to drug addiction, Neuroscience & Biobehavioral Reviews, 31, 1, 2007. Crossref

  142. He Shaunteng, Li Ning, Grasing Kenneth, Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference, Pharmacology Biochemistry and Behavior, 77, 2, 2004. Crossref

  143. Gao Jun, Zhu Ning, Feng Min, Meng Xiaolu, Sui Nan, Intra-nucleus-accumbens SKF38393 improved the impaired acquisition of morphine-conditioned place preference in depression-like rats, PsyCh Journal, 1, 1, 2012. Crossref

  144. Naranjo Claudio A., Tremblay Lescia K., Busto Usoa E., The role of the brain reward system in depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 4, 2001. Crossref

  145. Risinger Fred O, Brown Miriam M, Oakes Roger A, Love Julia A, Effects of Haloperidol or SCH-23390 on Ethanol-Induced Conditioned Taste Aversion, Alcohol, 18, 2-3, 1999. Crossref

  146. Jang Eun Young, Choe Eun Sang, Hwang Meeyul, Kim Sang Chan, Lee Jong Rok, Kim Sang Geon, Jeon Jae-Pil, Buono Russell J., Yang Chae Ha, Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABAB receptor, European Journal of Pharmacology, 587, 1-3, 2008. Crossref

  147. Zheng Fang-hao, Wei Ping, Huo Hui-ling, Xing Xue-feng, Chen Fei-long, Tan Xiao-mei, Luo Jia-bo, Neuroprotective Effect of Gui Zhi (Ramulus Cinnamomi) on Ma Huang- (Herb Ephedra-) Induced Toxicity in Rats Treated with a Ma Huang-Gui Zhi Herb Pair, Evidence-Based Complementary and Alternative Medicine, 2015, 2015. Crossref

  148. Bahi Amine, Dreyer Jean-Luc, Cocaine-induced expression changes of axon guidance molecules in the adult rat brain, Molecular and Cellular Neuroscience, 28, 2, 2005. Crossref

  149. Eugene Pekary A., Senanayake Shayani, Sattin Albert, Cocaine regulates TRH-related peptides in rat brain, Neurochemistry International, 41, 6, 2002. Crossref

  150. O'Brien Charles P., Gardner Eliot L., Critical assessment of how to study addiction and its treatment: Human and non-human animal models, Pharmacology & Therapeutics, 108, 1, 2005. Crossref

  151. Maldonado C, Cauli O, Rodrı́guez-Arias M, Aguilar M.A, Miñarro J, Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal, Behavioural Brain Research, 144, 1-2, 2003. Crossref

  152. Holahan Matthew R., Complementary roles for the amygdala and hippocampus during different phases of appetitive information processing, Neurobiology of Learning and Memory, 84, 2, 2005. Crossref

  153. Tzschentke T.M., Pharmacology and behavioral pharmacology of the mesocortical dopamine system, Progress in Neurobiology, 63, 3, 2001. Crossref

  154. Dobbs L.K., Mark G.P., Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse, Neuroscience, 156, 3, 2008. Crossref

  155. Gerrits M.A.F.M, Petromilli P, Westenberg H.G.M, Di Chiara G, van Ree J.M, Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats, Brain Research, 924, 2, 2002. Crossref

  156. Miller Dennis K., Rodvelt Kelli R., Constales Consuela, Putnam William C., Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity, Life Sciences, 81, 1, 2007. Crossref

  157. Ranaldi Robert, Wang Zhixia, Woolverton William L, Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys, Drug and Alcohol Dependence, 64, 2, 2001. Crossref

  158. Davis Lisa M., Pei Zhengtong, Trush Michael A., Cheskin Lawrence J., Contoreggi Carlo, McCullough Karen, Watkins Paul A., Moran Timothy H., Bromocriptine reduces steatosis in obese rodent models, Journal of Hepatology, 45, 3, 2006. Crossref

  159. Carr Kenneth D., Kutchukhidze Nino, Chronic food restriction increases Fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine, Brain Research, 861, 1, 2000. Crossref

  160. Werling Linda L., Reed Stephanie Collins, Wade Dean, Izenwasser Sari, Chronic nicotine alters cannabinoid‐mediated locomotor activity and receptor density in periadolescent but not adult male rats, International Journal of Developmental Neuroscience, 27, 3, 2009. Crossref

  161. Ferguson Susan M., Mitchell Ellen S., Neumaier John F., Increased Expression of 5-HT6 Receptors in the Nucleus Accumbens Blocks the Rewarding But Not Psychomotor Activating Properties of Cocaine, Biological Psychiatry, 63, 2, 2008. Crossref

  162. Rahman Shafiqur, Neugebauer Nichole M., Zhang Z., Crooks Peter A., Dwoskin Linda P., Bardo Michael T., The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens, Neuropharmacology, 52, 3, 2007. Crossref

  163. Gray Alex, Allison Claire, Pratt Judith A, A role for AMPA/kainate receptors in conditioned place preference induced by diazepam in the rat, Neuroscience Letters, 268, 3, 1999. Crossref

  164. Alvarez Edgardo O., Ruarte Marcela B., Role of glutamate receptors in the nucleus accumbens on behavioural responses to novel conflictive and non-conflictive environments in the rat, Behavioural Brain Research, 123, 2, 2001. Crossref

  165. Frantz K.J, Hansson K.J, Stouffer D.G, Parsons L.H, 5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine, Neuropharmacology, 42, 2, 2002. Crossref

  166. Venerosi Aldina, Valanzano Angela, Cirulli Francesca, Alleva Enrico, Calamandrei Gemma, Acute global anoxia during C-section birth affects dopamine-mediated behavioural responses and reactivity to stress, Behavioural Brain Research, 154, 1, 2004. Crossref

  167. Lin Yuan-Pin, Jung Tzyy-Ping, Wang and Julie Onton Yijun, Toward Affective Brain-Computer Interface: Fundamentals and Analysis of EEG-Based Emotion Classification, in Emotion Recognition, 2015. Crossref

  168. Hall F.S, Li X.F, Sora I, Xu F, Caron M, Lesch K.P, Murphy D.L, Uhl G.R, Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions, Neuroscience, 115, 1, 2002. Crossref

  169. Berridge Kent C, Robinson Terry E, What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?, Brain Research Reviews, 28, 3, 1998. Crossref

  170. Stairs Dustin J., Bardo Michael T., Neurobehavioral effects of environmental enrichment and drug abuse vulnerability, Pharmacology Biochemistry and Behavior, 92, 3, 2009. Crossref

  171. Kalivas Peter W, Nakamura Mitsuo, Neural systems for behavioral activation and reward, Current Opinion in Neurobiology, 9, 2, 1999. Crossref

  172. Giorgi O., Piras G., Lecca D., Corda M.G., Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: A comparative study in the Roman high- and low-avoidance rat lines, Neuroscience, 135, 3, 2005. Crossref

  173. Sidhu Anita, Niznik Hyman B., Coupling of dopamine receptor subtypes to multiple and diverse G proteins, International Journal of Developmental Neuroscience, 18, 7, 2000. Crossref

  174. Zou Mu-Fa, Agoston Gregory E, Belov Yuri, Kopajtic Theresa, Katz Jonathan L, Newman Amy Hauck, Enantioselective synthesis of S-(+)-2β-carboalkoxy-3α-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter, Bioorganic & Medicinal Chemistry Letters, 12, 9, 2002. Crossref

  175. Nikolaus Susanne, Huston Joseph P, Hasenöhrl Rüdiger U, Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor, European Journal of Pharmacology, 370, 2, 1999. Crossref

  176. Yan Qing-Shan, Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis, European Journal of Pharmacology, 385, 1, 1999. Crossref

  177. Zhu Jun, Green Thomas, Bardo Michael T, Dwoskin Linda P, Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex, Behavioural Brain Research, 148, 1-2, 2004. Crossref

  178. McCoy Michael T., Jayanthi Subramaniam, Wulu Jacqueline A., Beauvais Genevieve, Ladenheim Bruce, Martin Tracey A., Krasnova Irina N., Hodges Amber B., Cadet Jean Lud, Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection, Psychopharmacology, 215, 2, 2011. Crossref

  179. Spear L.P., The adolescent brain and age-related behavioral manifestations, Neuroscience & Biobehavioral Reviews, 24, 4, 2000. Crossref

  180. Polissidis Alexia, Chouliara Olga, Galanopoulos Andreas, Marselos Marios, Papadopoulou-Daifoti Zeta, Antoniou Katerina, Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure, Life Sciences, 85, 5-6, 2009. Crossref

  181. Corda Maria G., Piras Giovanna, Giorgi Osvaldo, Neonatal Ventral Hippocampal Lesions Potentiate Amphetamine-Induced Increments in Dopamine Efflux in the Core, but Not the Shell, of the Nucleus Accumbens, Biological Psychiatry, 60, 11, 2006. Crossref

  182. Ojanen Sami P., Palmén Maria, Hyytiä Petri, Kiianmaa Kalervo, Extracellular glutamate and GABA in the ventral tegmental area of alcohol-preferring AA and alcohol-avoiding ANA rats treated repeatedly with morphine, European Journal of Pharmacology, 559, 1, 2007. Crossref

  183. Mosher T.M., Smith J.G., Greenshaw A.J., Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats, Neuropharmacology, 51, 3, 2006. Crossref

  184. Carey Robert, Damianopoulos Ernest, DePalma Gail, The 5-HT1A antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine, Brain Research, 862, 1-2, 2000. Crossref

  185. Gawrysiak Michael J., Carvalho John P., Rogers Baxter P., Nicholas Christopher R. N., Dougherty John H., Hopko Derek R., Neural Changes following Behavioral Activation for a Depressed Breast Cancer Patient: A Functional MRI Case Study, Case Reports in Psychiatry, 2012, 2012. Crossref

  186. Ravna Aina Westrheim, Three-dimensional models of neurotransmitter transporters and their interactions with cocaine andS-citalopram, The World Journal of Biological Psychiatry, 7, 2, 2006. Crossref

  187. Gehrke B. J., Harrod S. B., Cass W. A., Bardo M. T., The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats, Psychopharmacology, 166, 3, 2003. Crossref

  188. Namburi Praneeth, Al-Hasani Ream, Calhoon Gwendolyn G, Bruchas Michael R, Tye Kay M, Architectural Representation of Valence in the Limbic System, Neuropsychopharmacology, 41, 7, 2016. Crossref

  189. Althobaiti Yusuf S., Alshehri Fahad S., Almalki Atiah H., Sari Youssef, Effects of Ceftriaxone on Glial Glutamate Transporters in Wistar Rats Administered Sequential Ethanol and Methamphetamine, Frontiers in Neuroscience, 10, 2016. Crossref

  190. Self David W, Neural substrates of drug craving and relapse in drug addiction, Annals of Medicine, 30, 4, 1998. Crossref

  191. Steele J Douglas, Lawrie Stephen M, Neuroimaging, in Companion to Psychiatric Studies, 2010. Crossref

  192. Gyertyán István, Gál Krisztina, Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference, NeuroReport, 14, 1, 2003. Crossref

  193. Le Merrer Julie, Becker Jérôme A. J., Befort Katia, Kieffer Brigitte L., Reward Processing by the Opioid System in the Brain, Physiological Reviews, 89, 4, 2009. Crossref

  194. Yonghui Li, Xigeng Zheng, Yunjing Bai, Xiaoyan Yang, Nan Sui, Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats, Journal of Psychopharmacology, 20, 1, 2006. Crossref

  195. Kalenscher Tobias, Lansink Carien S., Lankelma Jan V., Pennartz Cyriel M. A., Reward-Associated Gamma Oscillations in Ventral Striatum Are Regionally Differentiated and Modulate Local Firing Activity, Journal of Neurophysiology, 103, 3, 2010. Crossref

  196. Hjelmstad Gregory O., Fields Howard L., Kappa Opioid Receptor Inhibition of Glutamatergic Transmission in the Nucleus Accumbens Shell, Journal of Neurophysiology, 85, 3, 2001. Crossref

  197. Beeler Jeff, Should I Stay or Should I Go? Neural Substrates of Being in the Right Place at the Right Time. Focus on “How Prior Reward Experience Biases Exploratory Movements: A Probabilistic Model”, Journal of Neurophysiology, 97, 3, 2007. Crossref

  198. Bosch Oliver J., Young Larry J., Oxytocin and Social Relationships: From Attachment to Bond Disruption, in Behavioral Pharmacology of Neuropeptides: Oxytocin, 35, 2017. Crossref

  199. Achat-Mendes Cindy, Ali Syed F, Itzhak Yossef, Differential Effects of Amphetamines-Induced Neurotoxicity on Appetitive and Aversive Pavlovian Conditioning in Mice, Neuropsychopharmacology, 30, 6, 2005. Crossref

  200. German Paul W., Fields Howard L., Rat Nucleus Accumbens Neurons Persistently Encode Locations Associated With Morphine Reward, Journal of Neurophysiology, 97, 3, 2007. Crossref

  201. Fellous Jean-Marc, Neuromodulatory Basis of Emotion, The Neuroscientist, 5, 5, 1999. Crossref

  202. Shen Hao-wei, Hagino Yoko, Kobayashi Hideaki, Shinohara-Tanaka Keiko, Ikeda Kazutaka, Yamamoto Hideko, Yamamoto Toshifumi, Lesch Klaus-Peter, Murphy Dennis L, Hall F Scott, Uhl George R, Sora Ichiro, Regional Differences in Extracellular Dopamine and Serotonin Assessed by In Vivo Microdialysis in Mice Lacking Dopamine and/or Serotonin Transporters, Neuropsychopharmacology, 29, 10, 2004. Crossref

  203. Chen Jiang-Fan, Moratalla Rosario, Yu Liqun, Martín Ana B, Xu Kui, Bastia Elena, Hackett Elizabeth, Alberti Israel, Schwarzschild Michael A, Inactivation of Adenosine A2A Receptors Selectively Attenuates Amphetamine-Induced Behavioral Sensitization, Neuropsychopharmacology, 28, 6, 2003. Crossref

  204. Kr�gel Ute, Kittner Holger, Illes Peter, Mechanisms of adenosine 5?-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo, Synapse, 39, 3, 2001. Crossref

  205. Norton Camille S., Neal Charles R., Kumar Suneel, Akil Huda, Watson Stanley J., Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems, The Journal of Comparative Neurology, 444, 4, 2002. Crossref

  206. Ames Susan L., McBride Colleen, Translating Genetics, Cognitive Science, and Other Basic Science Research Findings Into Applications for Prevention, Evaluation & the Health Professions, 29, 3, 2006. Crossref

  207. Ye Hui, Wang Jingxin, Tian Zichuan, Ma Fengfei, Dowell James, Bremer Quentin, Lu Gaoyuan, Baldo Brian, Li Lingjun, Quantitative Mass Spectrometry Reveals Food Intake-Induced Neuropeptide Level Changes in Rat Brain: Functional Assessment of Selected Neuropeptides as Feeding Regulators, Molecular & Cellular Proteomics, 16, 11, 2017. Crossref

  208. Sharma Mona, Kumar Anand, Male Behaviors II: Neural Pathways Regulating Male Behaviors, in Basics of Human Andrology, 2017. Crossref

  209. Li Tao, Liu Xiehe, Zhao Jinghua, Hu Xun, Ball David M., Loh El-Wui, Sham Pak C., Collier David A., Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABAA?2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects, American Journal of Medical Genetics, 114, 3, 2002. Crossref

  210. Mateo Yolanda, Lack Christopher M, Morgan Drake, Roberts David C S, Jones Sara R, Reduced Dopamine Terminal Function and Insensitivity to Cocaine Following Cocaine Binge Self-Administration and Deprivation, Neuropsychopharmacology, 30, 8, 2005. Crossref

  211. Leri Francesco, Franklin Keith B. J., Diazepam in the ventral striatum dissociates dopamine-dependent and dopamine-independent place conditioning, NeuroReport, 11, 11, 2000. Crossref

  212. Ramalingam Mahesh, Kim Hyojung, Lee Yunjong, Lee Yun-Il, Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models, Frontiers in Aging Neuroscience, 10, 2018. Crossref

  213. Althobaiti Yusuf S., Alshehri Fahad S., Hakami Alqassem Y., Hammad Alaa M., Sari Youssef, Effects of Clavulanic Acid Treatment on Reinstatement to Methamphetamine, Glial Glutamate Transporters, and mGluR 2/3 Expression in P Rats Exposed to Ethanol, Journal of Molecular Neuroscience, 67, 1, 2019. Crossref

  214. Eiler William J.A., Seyoum Regat, Foster Katrina L., Mailey Chaz, June Harry L., D1 dopamine receptor regulates alcohol-motivated behaviors in the bed nucleus of the stria terminalis in alcohol-preferring (P) rats, Synapse, 48, 1, 2003. Crossref

  215. Levine Allen S, Kotz Catherine M, Gosnell Blake A, Sugars: hedonic aspects, neuroregulation, and energy balance, The American Journal of Clinical Nutrition, 78, 4, 2003. Crossref

  216. Simola Nicola, Brudzynski Stefan M., Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states, Journal of Neuroscience Methods, 310, 2018. Crossref

  217. Forster Gina L., Anderson Eden M., Scholl Jamie L., Lukkes Jodi L., Watt Michael J., Negative consequences of early-life adversity on substance use as mediated by corticotropin-releasing factor modulation of serotonin activity, Neurobiology of Stress, 9, 2018. Crossref

  218. Do Tien-Thong Nguyen, Chuang Chun-Hsiang, Hsiao Shih-Jie, Lin Chin-Teng, Wang Yu-Kai, Neural Comodulation of Independent Brain Processes Related to Multitasking, IEEE Transactions on Neural Systems and Rehabilitation Engineering, 27, 6, 2019. Crossref

  219. Shibasaki Masahiro, Katsura Masashi, Kurokawa Kazuhiro, Torigoe Fumiko, Ohkuma Seitaro, Regional Differences of L-type High Voltage-Gated Calcium Channel Subunit Expression in the Mouse Brain After Chronic Morphine Treatment, Journal of Pharmacological Sciences, 105, 2, 2007. Crossref

  220. Brust John C.M., The Neurobiology of Addiction, in Neurological Aspects of Substance Abuse, 2004. Crossref

  221. Gabrielsen Mari, Sylte Ingebrigt, Dahl Svein G, Ravna Aina W, A short update on the structure of drug binding sites on neurotransmitter transporters, BMC Research Notes, 4, 1, 2011. Crossref

  222. Marczak Ewa D., Jinsmaa Yunden, Li Tingyou, Bryant Sharon D., Tsuda Yuko, Okada Yoshio, Lazarus Lawrence H., [N-Allyl-Dmt1]-Endomorphins Are μ-Opioid Receptor Antagonists Lacking Inverse Agonist Properties, Journal of Pharmacology and Experimental Therapeutics, 323, 1, 2007. Crossref

  223. Bardo Michael T., Kelly Thomas, Lynam Donald R., Milich Richard, Basic Science and Drug Abuse Prevention: Neuroscience, Learning, and Personality Perspectives, in Handbook of Drug Abuse Prevention, 2006. Crossref

  224. Sofuoglu Mehmet, Kosten Thomas R, Novel Approaches to the Treatment of Cocaine Addiction, CNS Drugs, 19, 1, 2005. Crossref

  225. Hänsel Rudolf, Pertz Heinz, Alkaloide, in Pharmakognosie — Phytopharmazie, 2007. Crossref

  226. Ángel López-Vázquez Miguel, Érika Gutiérrez-Guzmán Blanca, Miguel Cervantes, Esther Olvera-Cortés María, 5-HT2C Receptors in Learning, in 5-HT2C Receptors in the Pathophysiology of CNS Disease, 2011. Crossref

  227. Middleton Lisa S., Cass Wayne A., Dwoskin Linda P., Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex, Journal of Pharmacology and Experimental Therapeutics, 308, 1, 2004. Crossref

  228. Panikkar Gopakumar P., Cocaine addiction: Neurobiology and related current research in pharmacotherapy, Substance Abuse, 20, 3, 1999. Crossref

  229. Dwoskin Linda P., Pivavarchyk Marharyta, Joyce B. Matthew, Neugebauer Nichole M., Zheng Guangrong, Zhang Zhenfa, Bardo Michael T., Crooks Peter A., Targeting Reward-Relevant Nicotinic Receptors in the Discovery of Novel Pharmacotherapeutic Agents to Treat Tobacco Dependence, in The Motivational Impact of Nicotine and its Role in Tobacco Use, 55, 2008. Crossref

  230. Miller Anthony D., Forster Gina L., Metcalf Kasey M., Falcon Alex J., Heruc Gabriella A., Blaha Charles D., Pedunculopontine and Laterodorsal Tegmental Lesion Effects on Drug-Evoked Behaviours and Forebrain Dopamine Efflux, in The Basal Ganglia VII, 52, 2002. Crossref

  231. Althobaiti Yusuf S., Almalki Atiah, Alsaab Hashem, Alsanie Walaa, Gaber Ahmed, Alhadidi Qasim, Hardy Ana Maria Gregio, Nasr Abdulrahman, Alzahrani Omar, Stary Creed M., Shah Zahoor A., Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism, Scientific Reports, 9, 1, 2019. Crossref

  232. Djouma Elvan, Lawrence Andrew J., The Effect of Chronic Ethanol Consumption and Withdrawal on μ-Opioid and Dopamine D1 and D2 Receptor Density in Fawn-Hooded Rat Brain, Journal of Pharmacology and Experimental Therapeutics, 302, 2, 2002. Crossref

  233. Gill Jan S, Biomedical links between cognitions and behaviour, in Cognitive-Behavioural Interventions in Physiotherapy and Occupational Therapy, 2008. Crossref

  234. Lewis Lucy R., Benn Abigail, Dwyer Dominic M., Robinson Emma S.J., Affective biases and their interaction with other reward-related deficits in rodent models of psychiatric disorders, Behavioural Brain Research, 372, 2019. Crossref

  235. Ravna Aina W., Sager Georg, Dahl Svein G., Sylte Ingebrigt, Membrane Transporters: Structure, Function and Targets for Drug Design, in Transporters as Targets for Drugs, 4, 2008. Crossref

  236. Tapia Melissa A., Sage Andrew S., Fullerton Emma I., Judd Jessica M., Hildebrant Paige C., Will Matthew J., Lever Susan Z., Lever John R., Miller Dennis K., The sigma receptor ligand N-phenylpropyl-N′-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice, Psychopharmacology, 237, 3, 2020. Crossref

  237. Bain John N., Prendergast Mark A., Terry Alvin V., Arneric Stephen P., Smith Mark A., Buccafusco Jerry J., Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential, Psychopharmacology, 169, 2, 2003. Crossref

  238. SHEARER JAMES, The principles of agonist pharmacotherapy for psychostimulant dependence, Drug and Alcohol Review, 27, 3, 2008. Crossref

  239. Kuperman P., Talmi D., Katz Np, Treister R., Certainty in ascending sensory signals – The unexplored driver of analgesic placebo response, Medical Hypotheses, 143, 2020. Crossref

  240. Khalil Rafaat , Humann Jessica , Testosterone modulation of ethanol effects on the �‑opioid receptor kinetics in castrated rats, Biomedical Reports, 2019. Crossref

  241. McGinn M. Adrienne, Pantazis Caroline B., Tunstall Brendan J., Marchette Renata C.N., Carlson Erika R., Said Nadia, Koob George F., Vendruscolo Leandro F., Drug addiction co-morbidity with alcohol: Neurobiological insights, in Neurobiology of Addiction and Co-Morbid Disorders, 157, 2021. Crossref

  242. Newman Amy Hauck, Robarge Michael J., Howard Ileana M., Wittkopp Sharine L., George Clifford, Kopajtic Theresa, Izenwasser Sari, Katz Jonathan L., Structure−Activity Relationships at Monoamine Transporters and Muscarinic Receptors for N-Substituted-3α-(3‘-chloro-, 4‘-chloro-, and 4‘,4‘ ‘-dichloro-substituted-diphenyl)methoxytropanes, Journal of Medicinal Chemistry, 44, 4, 2001. Crossref

  243. Doyno Cassandra R., White C. Michael, Sedative‐Hypnotic Agents That Impact Gamma‐Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma‐Hydroxybutyric Acid, Phenibut, and Selank, The Journal of Clinical Pharmacology, 61, S2, 2021. Crossref

  244. Tribrat Natalia, Knizhnik Yulia, Khusainov Denis, Tribrat Alexander, Dzjeldubaeva Elviza, Akishina Lyubov, Chornobay Svitlana, Prisnyi A., Lebedeva O., The evaluation of the grape polyphenoles nootropic activity in resveratrol and in the food concentrate “Enoant”, BIO Web of Conferences, 40, 2021. Crossref

  245. Wei Ze-Xu, Wu Qi, Liu Qing-Shan, Cheng Yong, Neurotransmitter system aberrations in patients with drug addiction, Journal of Neural Transmission, 127, 12, 2020. Crossref

  246. Wahba M. E. K., El Wasseef D., El Sherbiny D., Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit, Royal Society Open Science, 8, 5, 2021. Crossref

  247. García‐Cabrerizo Rubén, Carbia Carina, O´Riordan Kenneth J., Schellekens Harriet, Cryan John F., Microbiota‐gut‐brain axis as a regulator of reward processes, Journal of Neurochemistry, 157, 5, 2021. Crossref

  248. Althobaiti Yusuf S., Almutairi Farooq M., Alshehri Fahad S., Altowairqi Ebtehal, Marghalani Aliyah M., Alghorabi Amal A., Alsanie Walaa F., Gaber Ahmed, Alsaab Hashem O., Almalki Atiah H., Hakami Alqassem Y., Alkhalifa Turki, Almalki Ahmad D., Hardy Ana M. G., Shah Zahoor A., Involvement of the dopaminergic system in the reward-related behavior of pregabalin, Scientific Reports, 11, 1, 2021. Crossref

  249. Kutlu Munir Gunes, Gould Thomas J., Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction, Learning & Memory, 23, 10, 2016. Crossref

  250. Lewis Robert G., Florio Ermanno, Punzo Daniela, Borrelli Emiliana, The Brain’s Reward System in Health and Disease, in Circadian Clock in Brain Health and Disease, 1344, 2021. Crossref

  251. Hyman Steven E., Malenka Robert C., Nestler Eric J., NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory, Annual Review of Neuroscience, 29, 1, 2006. Crossref

  252. Wooters Thomas E, Neugebauer Nichole M, Rush Craig R, Bardo Michael T, Methylphenidate Enhances the Abuse-Related Behavioral Effects of Nicotine in Rats: Intravenous Self-Administration, Drug Discrimination, and Locomotor Cross-Sensitization, Neuropsychopharmacology, 33, 5, 2008. Crossref

  253. Hirakawa N, Tershner S.A, Fields H.L, Manning B.H, Bi-directional changes in affective state elicited by manipulation of medullary pain-modulatory circuitry, Neuroscience, 100, 4, 2000. Crossref

  254. Nazari Shahrzad, Pourmand Seyed Mahmoud, Makki Seyed Mohammad, Brand Serge, Vousooghi Nasim, Potential biomarkers of addiction identified by real-time PCR in human peripheral blood lymphocytes: a narrative review, Biomarkers in Medicine, 16, 9, 2022. Crossref

  255. Karimi-Haghighi Saeideh, Chavoshinezhad Sara, Mozafari Roghayeh, Noorbakhsh Farshid, Borhani-Haghighi Afshin, Haghparast Abbas, Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review, Cellular and Molecular Neurobiology, 2022. Crossref

  256. Tzschentke T M, Schmidt W J, Glutamatergic mechanisms in addiction, Molecular Psychiatry, 8, 4, 2003. Crossref

  257. Huang Kuan-Chih, John Alka Rachel, Jung Tzyy-Ping, Tsai Wen-Feng, Yu Yi-Hsin, Lin Chin-Teng, Comparing the Differences in Brain Activities and Neural Comodulations Associated With Motion Sickness Between Drivers and Passengers, IEEE Transactions on Neural Systems and Rehabilitation Engineering, 29, 2021. Crossref

  258. Archie Patrick, Bruera Eduardo, Cohen Lorenzo, Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature, Supportive Care in Cancer, 21, 9, 2013. Crossref

  259. David Vincent, Matifas Audrey, Gavello-Baudy Stéphanie, Decorte Laurence, Kieffer Brigitte L, Cazala Pierre, Brain Regional Fos Expression Elicited by the Activation of μ- but not δ-Opioid Receptors of the Ventral Tegmental Area: Evidence for an Implication of the Ventral Thalamus in Opiate Reward, Neuropsychopharmacology, 33, 7, 2008. Crossref

  260. Löffler Susanne, Gasca Fernando, Richter Lars, Leipscher Ulrike, Trillenberg Peter, Moser Andreas, The effect of repetitive transcranial magnetic stimulation on monoamine outflow in the nucleus accumbens shell in freely moving rats, Neuropharmacology, 63, 5, 2012. Crossref

  261. Meredith Gloria E., Totterdell Susan, Microcircuits in nucleus accumbens’ shell and core involved in cognition and reward, Psychobiology, 27, 2, 1999. Crossref

  262. Shahani Neelam, Swarnkar Supriya, Giovinazzo Vincenzo, Morgenweck Jenny, Bohn Laura M., Scharager-Tapia Catherina, Pascal Bruce, Martinez-Acedo Pablo, Khare Kshitij, Subramaniam Srinivasa, RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network (“Rhesactome”) in the striatum, Science Signaling, 9, 454, 2016. Crossref

  263. Schmidt Karl F., Febo Marcelo, Shen Qiang, Luo Feng, Sicard Kenneth M., Ferris Craig F., Stein Elliot A., Duong Timothy Q., Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI, Psychopharmacology, 185, 4, 2006. Crossref

  264. Blood Anne J., Zatorre Robert J., Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion, Proceedings of the National Academy of Sciences, 98, 20, 2001. Crossref

  265. Kalivas Peter W., Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity, Dialogues in Clinical Neuroscience, 9, 4, 2007. Crossref

  266. Maccioni Riccardo, Serra Marcello, Marongiu Jacopo, Cottiglia Filippo, Maccioni Elias, Bassareo Valentina, Morelli Micaela, Kasture Sanjay B., Acquas Elio, Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice, Psychopharmacology, 239, 3, 2022. Crossref

  267. Ghelardini Carla, Quattrone Alessandro, Galeotti Nicoletta, Livi Silvia, Banchelli Grazia, Raimondi Laura, Pirisino Renato, Antisense Knockdown of the Shaker-like Kv1.1 Gene Abolishes the Central Stimulatory Effects of Amphetamines in Mice and Rats, Neuropsychopharmacology, 28, 6, 2003. Crossref

  268. Kim Dahn Hyo, Yang Chae Ha, Hwang Meeyul, Sauchinone blocks methamphetamine-induced hyperlocomotion and place preference in mice, Phytomedicine, 20, 12, 2013. Crossref

  269. Chuang Shang-Wen, Ko Li-Wei, Lin Yuan-Pin, Huang Ruey-Song, Jung Tzyy-Ping, Lin Chin-Teng, Co-modulatory spectral changes in independent brain processes are correlated with task performance, NeuroImage, 62, 3, 2012. Crossref

  270. Atehortua Martinez Luisa Alessandra, Curis Emmanuel, Mekdad Nawel, Larrieu Claire, Courtin Cindie, Jourdren Laurent, Blugeon Corinne, Laplanche Jean-Louis, Megarbane Bruno, Marie-Claire Cynthia, Benturquia Nadia, Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence, Journal of Psychopharmacology, 36, 10, 2022. Crossref

  271. Pautassi Ricardo M., Wille-Bille Aranza, Fernández Macarena S., Fabio María Carolina, Ethanol Intake on Preclinical Models: Methods of Assessment and Effects on Dopamine Signaling, in Dopaminergic System Function and Dysfunction: Experimental Approaches, 193, 2023. Crossref

  272. Wang Zhiyan, Hou Chengqian, Chen Lei, Zhang Mingming, Luo Wenbo, Potential roles of the gut microbiota in the manifestations of drug use disorders, Frontiers in Psychiatry, 13, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain